EHR-based Screening and Intervention for Intimate Partner Violence
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 19,655
- Locations
- 2
- Primary Endpoint
- Screening completed (Yes/No)
Study Overview
Brief Summary
Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.
Detailed Description
The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Sequential
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 49 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Being an Medical University of South Carolina patient at primary care clinics (family medicine)
- •Women 18-49 years of age inclusive
- •Reported yes to wanting to be contacted for a follow-up research study
- •English-speaking
Exclusion Criteria
- •No exclusion criteria
Arms & Interventions
Sequence 2
5 clinics.
Intervention: Assessment and referral (Other)
Sequence 1
5 clinics. In stepped wedge design study, this was the sequence with shortest control (run-in) period.
All sequences have a run-in period and intervention period. In control period participants were screened using existing nurse-led oral screening, in intervention period both - nurse-led and our new confidential screen were used at the same time.
Intervention: Screening for intimate partner violence (Diagnostic Test)
Sequence 1
5 clinics. In stepped wedge design study, this was the sequence with shortest control (run-in) period.
All sequences have a run-in period and intervention period. In control period participants were screened using existing nurse-led oral screening, in intervention period both - nurse-led and our new confidential screen were used at the same time.
Intervention: Assessment and referral (Other)
Sequence 2
5 clinics.
Intervention: Screening for intimate partner violence (Diagnostic Test)
Sequence 3
5 clinics. This was the sequence with longest control (run-in) period.
Intervention: Screening for intimate partner violence (Diagnostic Test)
Sequence 3
5 clinics. This was the sequence with longest control (run-in) period.
Intervention: Assessment and referral (Other)
Outcomes
Primary Outcomes
Screening completed (Yes/No)
Time Frame: 29 months
Whether the assigned screening was completed during patient visit
IPV positive (Yes/No)
Time Frame: 29 months
Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative
Secondary Outcomes
- Severity of risk(29 months)
- Physician compliance with IPV management tools(29 months)
Investigators
Leslie Lenert
Professor-Faculty
Medical University of South Carolina